HI SB868 | 2018 | Regular Session

Note: Carry Over of previous SB868

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2017 - 25% progression, died in committee
Action: 2017-11-30 - Carried over to 2018 Regular Session.
Pending: Senate Public Safety, Intergovernmental and Military Affairs Committee
Text: Latest bill text (Amended) [HTML]

Summary

Amends Hawaii's controlled substances act to mirror federal regulations, which permit qualified practitioners to administer, dispense, and prescribe any schedule II, III, IV, or V narcotic drug approved by the Food and Drug Administration for use as a medically-managed withdrawal treatment, otherwise known as a detoxification treatment, or maintenance treatment; provided the practitioner complies with specific federal requirements. Allows physicians under certain circumstances to administer narcotic drugs to relieve acute withdrawal symptoms for not more than three days and to treat a person as an incidental adjunct to medical or surgical treatment. Effective 7/1/2050. (SD1)

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To The Controlled Substances Act.

Sponsors


History

DateChamberAction
2017-11-30 Carried over to 2018 Regular Session.
2017-02-16SenateReport adopted; Passed Second Reading, as amended (SD 1) and referred to PSM.
2017-02-16SenateReported from CPH (Stand. Com. Rep. No. 386) with recommendation of passage on Second Reading, as amended (SD 1) and referral to PSM.
2017-02-14SenateThe committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, Nishihara, S. Chang, Ihara, Kidani; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Espero, Ruderman.
2017-02-08SenateThe committee(s) on CPH deferred the measure until 02-14-17 10:00AM in conference room 229.
2017-02-02SenateThe committee(s) on CPH has scheduled a public hearing on 02-08-17 9:00AM in conference room 229.
2017-01-30SenateRe-Referred to CPH, PSM.
2017-01-30SenateThe committee(s) on PSM deleted the measure from the public hearing scheduled on 01-31-17 1:15PM in conference room 229.
2017-01-27SenateThe committee(s) on PSM has scheduled a public hearing on 01-31-17 1:15PM in conference room 229.
2017-01-25SenateReferred to PSM, CPH.
2017-01-25SenatePassed First Reading.
2017-01-25SenateIntroduced.

Same As/Similar To

HB1316 (Same As) 2018-01-17 - Re-referred to HHS, JUD, referral sheet 1
SB868 (Carry Over) 2017-02-16 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to PSM.

Subjects


Hawaii State Sources


Bill Comments

feedback